 
        Dr  
        Harriet  
        Oboge  
        
        Dr  
        Harriet  
        Oboge  
        Graduate Fellow  
        University of Nairobi, Faculty of Veterinary Medicine, Department of Public Health Pharmacology and Toxicology (PHPT)  
LinkedIn 
View profileBiography
        Dr. Harriet Matildah Oboge Epidemiologist | Veterinary Epidemiology Researcher | Impact-driven Scientist Overview: Dedicated to leveraging epidemiological research for the betterment of communities, Dr. Harriet Matildah Oboge is a dynamic researcher with a passion for multidisciplinary approaches to combatting infectious diseases. Currently pursuing her Ph.D. in Veterinary Epidemiology at the University of Nairobi, she is supported by the prestigious Feed the Future Animal Health Innovation for East Coast Fever control program, generously funded by USAID. Dr. Harriet's research endeavors are deeply rooted in creating tangible and positive impacts on household livelihoods, with a keen eye on fostering transformative change. Research Focus: Dr. Harriet's research spans a wide spectrum of topics within veterinary epidemiology, with a particular emphasis on infectious disease control and its socioeconomic implications. Her work is characterized by its interdisciplinary nature, seamlessly integrating epidemiological principles with economic analyses to provide comprehensive insights into disease dynamics and control strategies. She is particularly passionate about tackling East Coast Fever, a debilitating livestock disease prevalent in East Africa, and her research aims to develop innovative approaches for its prevention and control. Approach: Driven by a commitment to excellence and a genuine desire to make a difference.   Research interests
        Vaccinology, Epidemiology, Vaccine safety, Vaccine efficacy, Adjuvants, One-health,   Projects you're working on
        Improvement of East Coast fever live vaccine ands subunit vaccines using adjuvants  Discipline
        Bacteriology      Cellular biology      Challenge model development      Challenge study design      Clinical trials – efficacy      Clinical trials – safety      Economics      Epidemiology      Immunology – B-cells      Immunology – T-cells      Immunology – innate      Molecular biology      Safety evaluation      Statistics      Virology  Host species
        Camels      Cats      Cattle      Dogs      Horses      Pigs      Poultry      Small ruminants      Wildlife      Zoonoses  Pathogen
        Bacteria      Bacteria›Aeromonas      Bacteria›Brucella      Bacteria›Chlamydophila      Bacteria›Clostridia      Bacteria›E. coli      Bacteria›Leptospira      Bacteria›Mycobacteria bovis      Bacteria›Mycoplasma      Bacteria›Salmonella      Bacteria›Yersinia      Parasites      Parasites›Babesia      Parasites›Eimeria      Parasites›Nematodes      Parasites›Taenia solium      Parasites›Theileria annulata      Parasites›Theileria parva      Parasites›Ticks      Parasites›Trypanosoma      Viruses      Viruses›African horse sickness virus      Viruses›African swine fever virus      Viruses›Bluetongue virus      Viruses›Bovine ephemeral fever virus      Viruses›Bovine viral diarrhoea      Viruses›Capripoxvirus      Viruses›Classical swine fever virus      Viruses›Coronavirus      Viruses›Crimean-Congo haemorrhagic fever virus      Viruses›Ebolaviruses/filoviruses      Viruses›Foot-and-mouth disease virus      Viruses›Infectious bursal disease virus      Viruses›Mareks disease virus      Viruses›Newcastle disease virus      Viruses›Parainfluenza virus      Viruses›Peste des petits ruminants virus      Viruses›Porcine reproductive and respiratory syndrome virus      Viruses›Rabies virus      Viruses›Rift Valley fever virus  Stage of vaccine development
        Adjuvants      Antigen discovery and immunogen design      Clinical trials      Correlates of protection – immunomonitoring      Field trials      Pre-clinical trials      Vaccine delivery